ICI	Immune checkpoint inhibitors;
TIME	Tumor immune microenvironment;
PD-1	Programmed death1;
PD-L1	Programmed death ligand 1;
TCGA	The Cancer Genome Atlas;
TIL	Tumor-infiltrating lymphocyte;
TMB	Tumor mutation burden;
IHC	Immunohistochemistry;
THYM	Thymoma;
UCS	Uterine carcinosarcoma;
LUSC	Lung squamous cell carcinoma;
LIHC	Liver hepatocellular carcinoma;
TP53	Tumor protein 53;
TTN	Titin;
LRP1B	LDL receptor related protein 1B;
CSMD3	CUB and Sushi Multiple Domains 3;
BRAF	B-Raf Proto-Oncogene;
FAT1	FAT Atypical Cadherin 1;
GTF2I	General Transcription Factor Iii;
PCLO	Piccolo;
ZFHX4	Zinc Finger Homeobox 4;
SPTA1	Spectrin alpha, erythrocytic 1;
APC	Adenomatous polyposis coli;
KMT2D	Lysine methyltransferase 2D;
PIK3CA	Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;
PDCD1LG2	Programmed Cell Death 1 Ligand 2;
VTCN1	V-set domain containing T cell activation inhibitor 1;
PDCD1	Programmed Cell Death 1;
CTLA4	Cytotoxic T-lymphocyte-associated protein 4;
DEG	Different expressed gene;
KEGG	Kyoto Encyclopedia of Genes and Genomes;
IFNG	Interferon gamma;
TNF	Tumor necrosis factor;
TNFA	Tumor Necrosis Factor Alpha;
IL6	Interleukin 6;
IL12	Interleukin 12;
IL12A	Interleukin 12A;
IL12B	Interleukin 12B;
IL10	Interleukin 10;
GZMB	Granzyme B;
PRF1	Perforin-1;
KRAS	Kirsten ras;
VEGFA	Vascular endothelial growth factor A;
TGFB1	Transforming growth factor beta 1;
HRAS	HRas proto-oncogene;
IDH1	Isocitrate dehydrogenase (NADP(+)) 1;
POLE	DNA polymerase epsilon;
POLD1	DNA polymerase delta 1;
MUC16	Mucin 16;
RYR2	Ryanodine receptor 2;
SYNE1	Spectrin repeat containing nuclear envelope protein 1;
FLG	Filaggrin;
USH2A	Usherin;
CDKN2A	Cyclin dependent kinase inhibitor 2A;
MB21D2	Mab-21 domain containing 2;
NDUFA13	NADH:ubiquinone oxidoreductase subunit A13;
DGCR6L	DiGeorge syndrome critical region gene 6 like;
S100A1	S100 calcium binding protein A1;
IAPP	Islet amyloid polypeptide;
SLC3A2	Solute carrier family 3 member 2;
KLF3	Kruppel like factor 3;
GNG12	G protein subunit gamma 12;
NRAS	NRAS proto-oncogene;
RAB9B	RAB9B, member RAS oncogene family;
SH3BGRL2	SH3 domain binding glutamate rich protein like 2;
TNP1	Transition protein 1;
RPL22	Ribosomal protein L22;
MRPL22	Mitochondrial ribosomal protein L22;
CBLN3	Cerebellin 3 precursor;
PAIP2	Poly(A) binding protein interacting protein 2;
SEC61B	SEC61 translocon subunit beta;
DBI	Diazepam binding inhibitor;
GNA11	G protein subunit alpha 11;
ARHGAP1	Rho GTPase activating protein 1.